Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy

被引：0
|
作者：
Cruz Castellanos, P. [1 ]
Rosas Alonso, R. [1 ]
Ozaez, I. [1 ]
Hernandez, I. [1 ]
Losantos, I. [1 ]
Gutierrez Sainz, L. [1 ]
Higuera Gomez, O. [1 ]
Rodriguez Antolin, C. [1 ]
Esteban Rodriguez, I. [1 ]
Ibanez de Caceres, I. [1 ]
de Castro Carpeno, J. [1 ]
机构：
[1] Hosp Univ La Paz, IdiPAZ, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Non-small cell lung cancer; Next-Generation Sequencing (NGS); Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP16.01-00
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [31] Targeted Clinical Genotyping of Non-Small Cell Lung Cancers (NSCLC) Using Next-Generation Sequencing
    Pierce, K. J.
    Peterson, J. D.
    de Abreu, F. B.
    Padmanabhan, V.
    Black, C. C.
    Gutmann, E. J.
    Rigas, J. R.
    Dragnev, K. H.
    Amos, C. I.
    Tsongalis, G. J.
    Tafe, L. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 756 - 757
  • [32] Validation and implementation of next-generation sequencing in liquid biopsies by a novel NGS platform: Focus on non-small cell lung cancer
    Bisgin, Atil
    Sonmezler, Ozge
    Boga, Ibrahim
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [34] Optimal next-generation sequencing (NGS) panel for estimating tumor mutation burden (TMB) and its clinical implication for non-small cell lung cancer (NSCLC).
    Ikeda, Takaya
    Oi, Hajime
    Yoh, Kiyotaka
    Matsumoto, Shingo
    Kato, Terufumi
    Nishino, Kazumi
    Nakamura, Atsushi
    Nakachi, Ichiro
    Sakakibara-Konishi, Jun
    Daga, Haruko
    Furuya, Naoki
    Taima, Kageaki
    Iwama, Eiji
    Ebi, Noriyuki
    Shibata, Yuji
    Izumi, Hiroki
    Nosaki, Kaname
    Zenke, Yoshitaka
    Goto, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Concordance of MET Amplification between Fluorescence In Situ Hybridization (FISH) and Next-Generation Sequencing (NGS) in Non-Small Cell Lung Carcinoma (NSCLC)
    Ren, Rongqin
    Shiller, Michelle
    Chandra, Pranil
    Crawford, Eric
    Coldren, Christopher
    Yin, Lihui
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1654 - S1654
  • [36] VALUE OF DRIVER MUTATION TESTING STRATEGIES BASED ON NEXT-GENERATION SEQUENCING (NGS) FOR PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC)
    Liu, S.
    Shenolikar, R.
    Herrera-Restrepo, O.
    Anaya, P.
    Yu, H.
    VALUE IN HEALTH, 2021, 24 : S27 - S27
  • [37] Variant Detection and Tumor Mutational Burden (TMB) Concordance in Blood and Tumor Tissue Using Next-Generation Sequencing (NGS) in Patients with Non-small Cell Lung Cancer (NSCLC)
    Baden, J.
    Chang, H.
    Greenawalt, D. M.
    Kirov, S.
    Pant, S.
    Seminara, A.
    Srinivasan, S.
    Green, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1170 - 1170
  • [38] The correlation between crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer
    Lv, Tangfeng
    Zou, Qian
    Song, Zhengbo
    Liu, Hongbing
    Wang, Qiming
    Song, Yong
    JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 2948 - +
  • [39] The correlation between Crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer
    Lv, Tangfeng
    Song, Yong
    Zou, Qian
    Song, Zhengbo
    Liu, Hongbing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer (NSCLC) Using 454 Next-Generation Sequencing Technology
    Starostik, P.
    Deeb, K. K.
    Hohman, C. M.
    Risch, N. F.
    Metzger, D. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 932 - 933
12345